{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:10:22Z","timestamp":1790651422740,"version":"4.1.0"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:p>A recent technological advance that shows promise for applications in health care, including transplantation medicine, is the implementation of nanoparticles. Nanoparticles can be composed of a variety of organic or inorganic materials and confer many advantages over conventional treatments available, such as low toxicity, low-effective dosage required, and a high degree of manipulability. Although also used for imaging and diagnostics, nanoparticles\u2019 utility as a drug or genetic delivery system is of particular interest in transplantation medicine. Currently, researchers are exploring options to integrate nanoparticles into both diagnostics and therapy for both grafts ex-situ before transplantation and for patients following transplantation. These studies have demonstrated that nanoparticles can mitigate damage to organs and patients through a large variety of mechanisms\u2014ranging from the induction of cellular genetic changes to the enhancement of immunosuppressive drug delivery. Specifically, with the advent of machine perfusion preservation ex vivo, treatment of the graft became a very attractive approach and nanoparticles have great potential. However, before nanoparticles can be translated into clinical use, their short-term and long-term toxicity must be thoroughly characterized, especially with regards to their interactions with other biological molecules present in the human body.<\/jats:p>","DOI":"10.1097\/tp.0000000000003032","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T05:00:44Z","timestamp":1571979644000},"page":"682-693","source":"Crossref","is-referenced-by-count":41,"title":["Nanotechnology Applications in Transplantation Medicine"],"prefix":"10.1097","volume":"104","author":[{"given":"Christine G.","family":"Yao","sequence":"first","affiliation":[{"name":"Transplant Division, Department of Surgery, University of Massachusetts, Worcester, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo N.","family":"Martins","sequence":"additional","affiliation":[{"name":"Transplant Division, Department of Surgery, University of Massachusetts, Worcester, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20231002","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrd4503","article-title":"A holistic approach to targeting disease with polymeric nanoparticles.","volume":"14","author":"Cheng","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"R2-20231002","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/263797a0","article-title":"Polymers for the sustained release of proteins and other macromolecules.","volume":"263","author":"Langer","year":"1976","journal-title":"Nature"},{"key":"R3-20231002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1943089213506978","article-title":"Medical use of nanoparticles: drug delivery and diagnosis diseases.","volume":"1","author":"Nasimi","year":"2013","journal-title":"Int J Green Nanotechnol"},{"key":"R4-20231002","first-page":"318","article-title":"Role of nanoparticles in drug delivery system: a comprehensive review.","volume":"9","author":"Karuppusamy","year":"2017","journal-title":"J Pharm Sci"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/btm2.10003","article-title":"Nanoparticles in the clinic.","volume":"1","author":"Anselmo","year":"2016","journal-title":"Bioeng Transl Med"},{"key":"R6-20231002","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1111\/ajt.14963","article-title":"The future of marginal kidney repair in the context of normothermic machine perfusion.","volume":"18","author":"DiRito","year":"2018","journal-title":"Am J Transplant"},{"key":"R7-20231002","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejpb.2018.10.017","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers: a review emphasizing on particle structure and drug release.","volume":"133","author":"Gordillo-Galeano","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"E94","DOI":"10.3390\/nano7050094","article-title":"Recent advances in nanomaterials for gene delivery-a review.","volume":"7","author":"Riley","year":"2017","journal-title":"Nanomaterials"},{"key":"R9-20231002","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/IJN.S596","article-title":"Drug delivery and nanoparticles: applications and hazards.","volume":"3","author":"De Jong","year":"2008","journal-title":"Int J Nanomedicine"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.3389\/fimmu.2017.01888","article-title":"Nanoparticle-based modulation and monitoring of antigen-presenting cells in organ transplantation.","volume":"8","author":"Ochando","year":"2017","journal-title":"Front Immunol"},{"key":"R11-20231002","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1021\/nn800275r","article-title":"Self-assembled lipid\u2013polymer hybrid nanoparticles: a robust drug delivery platform.","volume":"2","author":"Zhang","year":"2008","journal-title":"ACS Nano"},{"key":"R12-20231002","doi-asserted-by":"crossref","first-page":"8887","DOI":"10.1016\/j.biomaterials.2014.06.044","article-title":"Nanoparticle delivery of donor antigens for transplant tolerance in allogeneic islet transplantation.","volume":"35","author":"Bryant","year":"2014","journal-title":"Biomaterials"},{"key":"R13-20231002","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.3727\/096368910X515863","article-title":"Assessment of human islet labeling with clinical grade iron nanoparticles prior to transplantation for graft monitoring by MRI.","volume":"19","author":"Ris","year":"2010","journal-title":"Cell Transplant"},{"key":"R14-20231002","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1208\/s12248-015-9780-2","article-title":"A review of clinical translation of inorganic nanoparticles.","volume":"17","author":"Anselmo","year":"2015","journal-title":"Aaps J"},{"key":"R15-20231002","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13287-018-0944-8","article-title":"Tracking embryonic hematopoietic stem cells to the bone marrow: nanoparticle options to evaluate transplantation efficiency.","volume":"9","author":"Sweeney","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"R16-20231002","first-page":"129","article-title":"Nanoparticles in modern medicine: state of the art and future challenges.","volume":"2","author":"Murthy","year":"2007","journal-title":"Int J Nanomedicine"},{"key":"R17-20231002","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.molmed.2018.05.003","article-title":"Focus on fundamentals: achieving effective nanoparticle targeting.","volume":"24","author":"Tietjen","year":"2018","journal-title":"Trends Mol Med"},{"key":"R18-20231002","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40472-015-0076-3","article-title":"Utilization of machine perfusion and nanotechnology for liver transplantation.","volume":"2","author":"Patel","year":"2015","journal-title":"Curr Transplant Rep"},{"key":"R19-20231002","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1111\/j.1600-6143.2011.03725.x","article-title":"Nanoparticle delivery of mycophenolic acid upregulates PD-L1 on dendritic cells to prolong murine allograft survival.","volume":"11","author":"Shirali","year":"2011","journal-title":"Am J Transplant"},{"key":"R20-20231002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.04.011","article-title":"Bilirubin nanoparticle preconditioning protects against hepatic ischemia-reperfusion injury.","volume":"133","author":"Kim","year":"2017","journal-title":"Biomaterials"},{"key":"R21-20231002","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3727\/215517912X639397","article-title":"Novel positive-charged nanoparticles for efficient magnetic resonance imaging of islet transplantation.","volume":"3","author":"Oishi","year":"2012","journal-title":"Cell Med"},{"key":"R22-20231002","doi-asserted-by":"crossref","first-page":"e57046","DOI":"10.1371\/journal.pone.0057046","article-title":"In vivo imaging of transplanted islets labeled with a novel cationic nanoparticle.","volume":"8","author":"Oishi","year":"2013","journal-title":"PLoS One"},{"key":"R23-20231002","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jmmm.2006.10.1148","article-title":"Use of a SQUID array to detect T-cells with magnetic nanoparticles in determining transplant rejection.","volume":"311","author":"Flynn","year":"2007","journal-title":"J Magn Magn Mater"},{"key":"R24-20231002","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/mrm.24768","article-title":"In vivo imaging of islet transplantation using PLGA nanoparticles containing iron oxide and indocyanine green.","volume":"71","author":"Hwang","year":"2014","journal-title":"Magn Reson Med"},{"key":"R25-20231002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.aam6764","article-title":"Nanoparticle targeting to the endothelium during normothermic machine perfusion of human kidneys.","volume":"9","author":"Tietjen","year":"2017","journal-title":"Sci Transl Med"},{"key":"R26-20231002","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/lt.21001","article-title":"Delivery of antioxidative enzyme genes protects against ischemia\/reperfusion-induced liver injury in mice.","volume":"12","author":"He","year":"2006","journal-title":"Liver Transpl"},{"key":"R27-20231002","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1111\/j.1600-6143.2011.03660.x","article-title":"Targeted gene silencing of TLR4 using liposomal nanoparticles for preventing liver ischemia reperfusion injury.","volume":"11","author":"Jiang","year":"2011","journal-title":"Am J Transplant"},{"key":"R28-20231002","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.jhep.2019.01.019","article-title":"Nucleotide-binding oligomerization domain 1 (NOD1) modulates liver ischemia reperfusion through the expression adhesion molecules.","volume":"70","author":"Lassailly","year":"2019","journal-title":"J Hepatol"},{"key":"R29-20231002","doi-asserted-by":"crossref","first-page":"25909","DOI":"10.1039\/C8RA01555D","article-title":"Organ preservation with targeted rapamycin nanoparticles: a pre-treatment strategy preventing chronic rejection in vivo.","volume":"8","author":"Zhu","year":"2018","journal-title":"RSC Adv"},{"key":"R30-20231002","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/stem.2777","article-title":"Poly(lactide-co-glycolide)-monomethoxy-poly-(polyethylene glycol) nanoparticles loaded with melatonin protect adipose-derived stem cells transplanted in infarcted heart tissue.","volume":"36","author":"Ma","year":"2018","journal-title":"Stem Cells"},{"key":"R31-20231002","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.biopha.2016.04.064","article-title":"Carnosic acid nanoparticles suppress liver ischemia\/reperfusion injury by inhibition of ROS, caspases and NF-\u03bab signaling pathway in mice.","volume":"82","author":"Li","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"R32-20231002","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.comppsych.2017.12.002","article-title":"Precuneus-related regional and network functional deficits in social anxiety disorder: a resting-state functional MRI study.","volume":"82","author":"Yuan","year":"2018","journal-title":"Compr Psychiatry"},{"key":"R33-20231002","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/jphp.12089","article-title":"Rapamycin-loaded poly(\u03b5-caprolactone)-poly(ethylene glycol)-poly(\u03b5-caprolactone) nanoparticles: preparation, characterization and potential application in corneal transplantation.","volume":"66","author":"Zhang","year":"2014","journal-title":"J Pharm Pharmacol"},{"key":"R34-20231002","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ijpharm.2007.07.045","article-title":"Preparation of rapamycin-loaded chitosan\/PLA nanoparticles for immunosuppression in corneal transplantation.","volume":"349","author":"Yuan","year":"2008","journal-title":"Int J Pharm"},{"key":"R35-20231002","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.2147\/IJN.S24567","article-title":"Prevention of acute graft-versus-host disease by magnetic nanoparticles of fe3O4 combined with cyclosporin A in murine models.","volume":"6","author":"Cheng","year":"2011","journal-title":"Int J Nanomedicine"},{"key":"R36-20231002","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.immuni.2018.09.008","article-title":"Inhibiting inflammation with myeloid cell-specific nanobiologics promotes organ transplant acceptance.","volume":"49","author":"Braza","year":"2018","journal-title":"Immunity"},{"key":"R37-20231002","doi-asserted-by":"crossref","first-page":"43552","DOI":"10.1039\/C5RA04057D","article-title":"Immunosuppressive nano-therapeutic micelles downregulate endothelial cell inflammation and immunogenicity.","volume":"5","author":"Nadig","year":"2015","journal-title":"RSC Adv"},{"key":"R38-20231002","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1111\/ajt.14266","article-title":"Novel application of localized nanodelivery of anti-interleukin-6 protects organ transplant from ischemia-reperfusion injuries.","volume":"17","author":"Solhjou","year":"2017","journal-title":"Am J Transplant"},{"key":"R39-20231002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2015.10.041","article-title":"Tolerance induction using nanoparticles bearing HY peptides in bone marrow transplantation.","volume":"76","author":"Hlavaty","year":"2016","journal-title":"Biomaterials"},{"key":"R40-20231002","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1432-2277.2006.00301.x","article-title":"Modifying graft immunogenicity and immune response prior to transplantation: potential clinical applications of donor and graft treatment.","volume":"19","author":"Martins","year":"2006","journal-title":"Transpl Int"},{"issue":"Suppl 1","key":"R41-20231002","doi-asserted-by":"crossref","first-page":"i29","DOI":"10.1093\/bja\/aer384","article-title":"Organ transplantation: historical perspective and current practice.","volume":"108","author":"Watson","year":"2012","journal-title":"Br J Anaesth"},{"key":"R42-20231002","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1053\/j.gastro.2018.12.037","article-title":"Evolving trends in machine perfusion for liver transplantation.","volume":"156","author":"Dutkowski","year":"2019","journal-title":"Gastroenterology"},{"issue":"3 Suppl","key":"R43-20231002","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.cryobiol.2009.10.006","article-title":"Current state of hypothermic machine perfusion preservation of organs: the clinical perspective.","volume":"60","author":"Taylor","year":"2010","journal-title":"Cryobiology"},{"key":"R44-20231002","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s40472-017-0144-y","article-title":"Opportunities for therapeutic intervention during machine perfusion.","volume":"4","author":"Karimian","year":"2017","journal-title":"Curr Transplant Rep"},{"key":"R45-20231002","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/tri.13441","article-title":"The future of organ perfusion and re-conditioning.","volume":"32","author":"Weissenbacher","year":"2019","journal-title":"Transpl Int"},{"key":"R46-20231002","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1097\/TP.0000000000002642","article-title":"Nanoparticle release by extended criteria donor kidneys during normothermic machine perfusion.","volume":"103","author":"Woud","year":"2019","journal-title":"Transplantation"},{"key":"R47-20231002","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1097\/TP.0000000000001856","article-title":"Exosomes: from cell debris to potential biomarkers in transplantation.","volume":"101","author":"Morelli","year":"2017","journal-title":"Transplantation"},{"key":"R48-20231002","first-page":"1943","article-title":"Development of antibody-tagged nanoparticles for detection of transplant rejection using biomagnetic sensors.","volume":"22","author":"Butler","year":"2013","journal-title":"Transplantation"},{"key":"R49-20231002","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41467-017-00297-x","article-title":"Ex vivo pretreatment of human vessels with siRNA nanoparticles provides protein silencing in endothelial cells.","volume":"8","author":"Cui","year":"2017","journal-title":"Nat Commun"},{"key":"R50-20231002","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1097\/TP.0000000000002515","article-title":"First report of sirna uptake (for RNA interference) during ex vivo hypothermic and normothermic liver machine perfusion.","volume":"103","author":"Gillooly","year":"2019","journal-title":"Transplantation"},{"issue":"Suppl 3","key":"R51-20231002","article-title":"Gene silencing with p53 si-RNA downregulates inflammatory markers in the liver: potential utilization during normothermic machine preservation.","volume":"17","author":"Moore","year":"2017","journal-title":"Am J Transplant"},{"key":"R52-20231002","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.biomaterials.2019.04.030","article-title":"Optimizing PLG nanoparticle-peptide delivery platforms for transplantation tolerance using an allogeneic skin transplant model.","volume":"210","author":"Shah","year":"2019","journal-title":"Biomaterials"},{"key":"R53-20231002","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1097\/TP.0000000000001100","article-title":"The emerging role of nanotechnology in cell and organ transplantation.","volume":"100","author":"Tasciotti","year":"2016","journal-title":"Transplantation"},{"key":"R54-20231002","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3727\/096368912X657963","article-title":"Development of antibody-tagged nanoparticles for detection of transplant rejection using biomagnetic sensors.","volume":"22","author":"Butler","year":"2013","journal-title":"Cell Transplant"},{"key":"R55-20231002","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nm0416-446e","article-title":"Corrigendum: long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice.","volume":"22","author":"Vegas","year":"2016","journal-title":"Nat Med"},{"key":"R56-20231002","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/jat.3499","article-title":"Review of the effects of manufactured nanoparticles on mammalian target organs.","volume":"38","author":"Wu","year":"2018","journal-title":"J Appl Toxicol"},{"key":"R57-20231002","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3762\/bjnano.9.98","article-title":"Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations.","volume":"9","author":"Jeevanandam","year":"2018","journal-title":"Beilstein J Nanotechnol"},{"key":"R58-20231002","doi-asserted-by":"crossref","first-page":"447","DOI":"10.15171\/apb.2015.061","article-title":"A review of molecular mechanisms involved in toxicity of nanoparticles.","volume":"5","author":"Khalili Fard","year":"2015","journal-title":"Adv Pharm Bull"},{"key":"R59-20231002","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2217\/nnm.14.81","article-title":"Development of nanoparticles for clinical use.","volume":"9","author":"Skotland","year":"2014","journal-title":"Nanomedicine (Lond)"},{"key":"R60-20231002","first-page":"1","article-title":"Novel nanoparticle materials for drug\/food delivery-polysaccharides.","volume":"1","author":"Chen","year":"2016","journal-title":"Phys Sci Rev"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:08:02Z","timestamp":1696223282000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003032","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}